Plasma Therapy Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the plasma therapy market looks promising with opportunities in applications, like orthopedics, dermatology, dental, cardiac mucle injury, and nerve injury. The global plasma therapy market is expected to grow with a CAGR of 12%-16% from 2020 to 2025. The major drivers for this market are increasing incidence of sports injuries, arthritis, and growing use of platelet-rich plasma in various therapeutic areas.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global plasma therapy market report, please download the report brochure.
In this market, pure PRP is the largest type of plasma therapy, whereas hospitals & clinics is the largest end user. Growth in various segments of the plasma therapy market are given below:
The study includes trends and forecast for the global plasma therapy market by type, source, application, end user, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Pure PRP (Platelet-Rich Plasma)
Leucocyte-Rich PRP
Pure Platelet-Rich Fibrin (PRF)
Leukocyte-Rich Fibrin (L-PRF)
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
Autologous
Allogenic
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Orthopedics
Dermatology
Dental
Cardiac Muscle Injury
Nerve Injury
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals & Clinics
Research Institutions
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the plasma therapy model companies profiled in this report include BioLife Plasma, Cambryn Biologics, Biotest, CSL, Grifols, Kedrion, LFB, Bio Products Laboratory, China Biologic Products, and Octapharma.
Lucintel forecasts that pure PRP will remain the largest type segment over the forecast period due to effective results of pure PRP.
Within this market, hospitals and clinics will remain the largest end user segment over the forecast period due to an increase in healthcare expenditure and rise in the use of PRP products in hospitals.
North America will remain the largest region over the forecast period due to increasing awareness of plasma therapy and its acceptance as a suitable remedy for healing of bones and other tissues.
Features of the Global Plasma Therapy Market
Market Size Estimates: Global plasma therapy market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global plasma therapy market size by various segments, such as type, source, application, and end user in terms of value.Regional Analysis: Global plasma therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different type, source, application, end user, and region for the global plasma therapy market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global plasma therapy market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global plasma therapy market by type (pure PRP (platelet-rich plasma), leucocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF)), source (autologous and allogenic), application (orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others), and end user (hospitals & clinics and research institutions), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global plasma therapy market?
Q.5 What are the business risks and threats to the global plasma therapy market?
Q.6 What are the emerging trends in this plasma therapy market and the reasons behind them?
Q.7 What are some changing demands of customers in this plasma therapy market?
Q.8 What are the new developments in this plasma therapy market? Which companies are leading these developments?
Q.9 Who are the major players in this plasma therapy market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this plasma therapy market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global plasma therapy market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Type Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Pure PRP (Platelet-Rich Plasma), Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), and Leukocyte-rich Fibrin (L-PRF)), Source (Autologous and Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others), and End User (Hospitals & Clinics and Research Institutions)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the plasma therapy market looks promising with opportunities in applications, like orthopedics, dermatology, dental, cardiac mucle injury, and nerve injury. The global plasma therapy market is expected to grow with a CAGR of 12%-16% from 2020 to 2025. The major drivers for this market are increasing incidence of sports injuries, arthritis, and growing use of platelet-rich plasma in various therapeutic areas.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global plasma therapy market report, please download the report brochure.
In this market, pure PRP is the largest type of plasma therapy, whereas hospitals & clinics is the largest end user. Growth in various segments of the plasma therapy market are given below:
The study includes trends and forecast for the global plasma therapy market by type, source, application, end user, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Pure PRP (Platelet-Rich Plasma)
Leucocyte-Rich PRP
Pure Platelet-Rich Fibrin (PRF)
Leukocyte-Rich Fibrin (L-PRF)
By Source [Value ($ Million) shipment analysis for 2014 – 2025]:
Autologous
Allogenic
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Orthopedics
Dermatology
Dental
Cardiac Muscle Injury
Nerve Injury
Others
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Hospitals & Clinics
Research Institutions
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Spain
Germany
France
Asia Pacific
China
India
Japan
The Rest of the World
Brazil
Some of the plasma therapy model companies profiled in this report include BioLife Plasma, Cambryn Biologics, Biotest, CSL, Grifols, Kedrion, LFB, Bio Products Laboratory, China Biologic Products, and Octapharma.
Lucintel forecasts that pure PRP will remain the largest type segment over the forecast period due to effective results of pure PRP.
Within this market, hospitals and clinics will remain the largest end user segment over the forecast period due to an increase in healthcare expenditure and rise in the use of PRP products in hospitals.
North America will remain the largest region over the forecast period due to increasing awareness of plasma therapy and its acceptance as a suitable remedy for healing of bones and other tissues.
Features of the Global Plasma Therapy Market
Market Size Estimates: Global plasma therapy market size estimation in terms of value ($M) shipment.Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.Segmentation Analysis: Global plasma therapy market size by various segments, such as type, source, application, and end user in terms of value.Regional Analysis: Global plasma therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.Growth Opportunities: Analysis of growth opportunities in different type, source, application, end user, and region for the global plasma therapy market.Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global plasma therapy market.Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global plasma therapy market by type (pure PRP (platelet-rich plasma), leucocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF)), source (autologous and allogenic), application (orthopedics, dermatology, dental, cardiac muscle injury, nerve injury, and others), and end user (hospitals & clinics and research institutions), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global plasma therapy market?
Q.5 What are the business risks and threats to the global plasma therapy market?
Q.6 What are the emerging trends in this plasma therapy market and the reasons behind them?
Q.7 What are some changing demands of customers in this plasma therapy market?
Q.8 What are the new developments in this plasma therapy market? Which companies are leading these developments?
Q.9 Who are the major players in this plasma therapy market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this plasma therapy market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global plasma therapy market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Type Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Pure PRP (Platelet-Rich Plasma), Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), and Leukocyte-rich Fibrin (L-PRF)), Source (Autologous and Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others), and End User (Hospitals & Clinics and Research Institutions)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Plasma Therapy Market Trends and Forecast
3.3: Global Plasma Therapy Market by Type
3.3.1: Pure PRP (Platelet-Rich Plasma)
3.3.2: Leucocyte-Rich PRP
3.3.3: Pure Platelet-Rich Fibrin (PRF)
3.3.4: Leukocyte-Rich Fibrin (L-PRF)
3.4: Global Plasma Therapy Market by Source
3.4.1: Autologous
3.4.2: Allogenic
3.5: Global Plasma Therapy Market by Application
3.5.1: Orthopedics
3.5.2: Dermatology
3.5.3: Dental
3.5.4: Cardiac Muscle Injury
3.5.5: Nerve Injury
3.5.6: Others
3.6: Global Plasma Therapy Market by End User
3.6.1: Hospitals & Clinics
3.6.2: Research Institutions
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Plasma Therapy Market by Region
4.2: North American Plasma Therapy Market
4.2.1: Market by Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.2.2: Market by Source: Autologous and Allogenic
4.2.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.2.4: Market by End User: Hospitals & Clinics and Research Institutions
4.2.5: The United States Plasma Therapy Market
4.2.6: The Canadian Plasma Therapy Market
4.2.7: The Mexican Plasma Therapy Market
4.3: European Plasma Therapy Market
4.3.1: Market by Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.3.2: Market by Source: Autologous and Allogenic
4.3.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.3.4: Market by End User: Hospitals & Clinics and Research Institutions
4.3.5: The United Kingdom Plasma Therapy Market
4.3.6: The Spanish Plasma Therapy Market
4.3.7: The German Plasma Therapy Market
4.3.8: The French Plasma Therapy Market
4.4: APAC Plasma Therapy Market
4.4.1: Market by Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.4.2: Market by Source: Autologous and Allogenic
4.4.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.4.4: Market by End User: Hospitals & Clinics and Research Institutions
4.4.5: The Chinese Plasma Therapy Market
4.4.6: The Indian Plasma Therapy Market
4.4.7: The Japanese Plasma Therapy Market
4.5: ROW Plasma Therapy Market
4.5.1: Market By Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.5.2: Market by Source: Autologous and Allogenic
4.5.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.5.4: Market by End User: Hospitals & Clinics and Research Institutions
4.5.5: Brazilian Plasma Therapy Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Type Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Plasma Therapy Market by Type
7.1.2: Growth Opportunities for the Global Plasma Therapy Market by Source
7.1.3: Growth Opportunities for the Global Plasma Therapy Market by Application
7.1.4: Growth Opportunities for the Global Plasma Therapy Market by End User
7.1.5: Growth Opportunities for the Global Plasma Therapy Market by Region
7.2: Emerging Trends in the Global Plasma Therapy Market
7.3: Strategic Analysis
7.3.1: New Type Development
7.3.2: Capacity Expansion of the Global Plasma Therapy Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Plasma Therapy Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: BioLife Plasma Services
8.2: Cambryn Biologics LLC
8.3: Biotest
8.4: CSL Ltd.
8.5: Grifols International S.A.
8.6: Kedrion S.p.A.
8.7: LFB
8.8: Bi Products Laboratory Ltd.
8.9: China Biologic Products, Inc.
8.10: Octapharma
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Plasma Therapy Market Trends and Forecast
3.3: Global Plasma Therapy Market by Type
3.3.1: Pure PRP (Platelet-Rich Plasma)
3.3.2: Leucocyte-Rich PRP
3.3.3: Pure Platelet-Rich Fibrin (PRF)
3.3.4: Leukocyte-Rich Fibrin (L-PRF)
3.4: Global Plasma Therapy Market by Source
3.4.1: Autologous
3.4.2: Allogenic
3.5: Global Plasma Therapy Market by Application
3.5.1: Orthopedics
3.5.2: Dermatology
3.5.3: Dental
3.5.4: Cardiac Muscle Injury
3.5.5: Nerve Injury
3.5.6: Others
3.6: Global Plasma Therapy Market by End User
3.6.1: Hospitals & Clinics
3.6.2: Research Institutions
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Plasma Therapy Market by Region
4.2: North American Plasma Therapy Market
4.2.1: Market by Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.2.2: Market by Source: Autologous and Allogenic
4.2.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.2.4: Market by End User: Hospitals & Clinics and Research Institutions
4.2.5: The United States Plasma Therapy Market
4.2.6: The Canadian Plasma Therapy Market
4.2.7: The Mexican Plasma Therapy Market
4.3: European Plasma Therapy Market
4.3.1: Market by Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.3.2: Market by Source: Autologous and Allogenic
4.3.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.3.4: Market by End User: Hospitals & Clinics and Research Institutions
4.3.5: The United Kingdom Plasma Therapy Market
4.3.6: The Spanish Plasma Therapy Market
4.3.7: The German Plasma Therapy Market
4.3.8: The French Plasma Therapy Market
4.4: APAC Plasma Therapy Market
4.4.1: Market by Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.4.2: Market by Source: Autologous and Allogenic
4.4.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.4.4: Market by End User: Hospitals & Clinics and Research Institutions
4.4.5: The Chinese Plasma Therapy Market
4.4.6: The Indian Plasma Therapy Market
4.4.7: The Japanese Plasma Therapy Market
4.5: ROW Plasma Therapy Market
4.5.1: Market By Type: Pure PRP (Platelet-Rich Plasma), Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin (PRF), and Leukocyte-Rich Fibrin (L-PRF))
4.5.2: Market by Source: Autologous and Allogenic
4.5.3: Market by Application: Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others
4.5.4: Market by End User: Hospitals & Clinics and Research Institutions
4.5.5: Brazilian Plasma Therapy Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Type Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Plasma Therapy Market by Type
7.1.2: Growth Opportunities for the Global Plasma Therapy Market by Source
7.1.3: Growth Opportunities for the Global Plasma Therapy Market by Application
7.1.4: Growth Opportunities for the Global Plasma Therapy Market by End User
7.1.5: Growth Opportunities for the Global Plasma Therapy Market by Region
7.2: Emerging Trends in the Global Plasma Therapy Market
7.3: Strategic Analysis
7.3.1: New Type Development
7.3.2: Capacity Expansion of the Global Plasma Therapy Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Plasma Therapy Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: BioLife Plasma Services
8.2: Cambryn Biologics LLC
8.3: Biotest
8.4: CSL Ltd.
8.5: Grifols International S.A.
8.6: Kedrion S.p.A.
8.7: LFB
8.8: Bi Products Laboratory Ltd.
8.9: China Biologic Products, Inc.
8.10: Octapharma
